2022
DOI: 10.1001/jamadermatol.2022.2383
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous T-Cell–Rich Lymphoid Infiltrates After SARS-CoV-2 Vaccination

Abstract: The most common skin reactions to mRNA-based vaccination against SARS-CoV-2 have included local and delayed injection site reactions and urticaria and have been more frequently associated with the Moderna vaccine vs the Pfizer/ BioNTech vaccine. 1 To our knowledge, cutaneous lymphoid reactions to COVID-19 vaccination have yet to be assessed in comprehensive vaccine studies.Methods | From March to November 21, in accordance with a Northwestern University institutional review boardapproved protocol, this retrosp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(22 citation statements)
references
References 7 publications
0
20
0
Order By: Relevance
“…6 These local pseudolymphomatous responses at the injection site have also been described with other types of vaccines, including vaccines against early summer meningoencephalitis, tetanus, hepatitis A and B, 7,8 and the anti-COVID vaccine. 9,10 Pseudolymphomatous responses have also been described after injections of allergens. 11…”
Section: Discussionmentioning
confidence: 99%
“…6 These local pseudolymphomatous responses at the injection site have also been described with other types of vaccines, including vaccines against early summer meningoencephalitis, tetanus, hepatitis A and B, 7,8 and the anti-COVID vaccine. 9,10 Pseudolymphomatous responses have also been described after injections of allergens. 11…”
Section: Discussionmentioning
confidence: 99%
“…10 Indeed, 4 cases of LyP have been reported after the first dose of COVID-19 vaccination. 11,12 All cases except 1 were caused by the…”
Section: Discussionmentioning
confidence: 99%
“…10 Indeed, 4 cases of LyP have been reported after the first dose of COVID-19 vaccination. 11,12 All cases except 1 were caused by the BNT162b2 vaccine. It is worth noting that 3 of them, including ours, regardless of their histological type, exhibit an acral distribution.…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, in a recent case series, low‐grade cutaneous lymphoid reactions after COVID‐19 vaccination have been observed. 7 Recurrence of pre‐existing complete remission PCLDs has also been described following COVID‐19 vaccine, with several case reported so far. 3 , 8 , 9 The overproduction and exhaustion of CD4+ and CD8+ lymphocytes, expressing CD30 after being triggered by the vaccine, might be held responsible for the disease recurrence.…”
Section: Figurementioning
confidence: 98%